Appendix A: List of Abbreviations

Updated
Reviewed
May. 07, 2013

Abbreviations
Acronym/
Abbreviation
Definition
ABGs arterial blood gasses
ACTG AIDS Clinical Trials Group
AFB acid-fact bacilli
AIN anal intraepithelial neoplasia
ALT alanine aminotransferase
anti-HBc hepatitis B core antibody
anti-HBs hepatitis B surface antibody
ART antiretroviral therapy
ARV antiretroviral
ASCCP American Society for Colposcopy and Cervical Pathology
ASC-H atypical squamous cells—cannot exclude high grade
cervical squamous intraepithelial lesion
ASC-US atypical squamous cells of uncertain significance
AST serum aspartate aminotransferase
AUC area under the curve
BA bacillary angiomatosis
BAL bronchoalveolar lavage
BID twice a day
BIW twice a week
CAP community-acquired pneumonia
CAPD continuous ambulatory peritoneal dialysis
CD4 CD4 T lymphocyte cell
CDC Centers for Disease Control and Prevention
CDI Clostridium difficile-associated infection
CES-D Center for Epidemiologic Studies Depression Scale
CFU colony-forming unit
CIA chemiluminescence immunoassays
CIN cervical intraepithelial neoplasia
Cmax maximum concentration
Cmin minimum concentration
CMV cytomegalovirus
CNS central nervous system
CPE central nervous system penetration effectiveness
CrCl creatinine clearance
CSF cerebrospinal fluid
CT computed tomography
CYP3A4 Cytochrome P450 3A4
DAAs direct acting antiviral agents
DOT directly observed therapy
DS double strength
EDTA ethylenediaminetetraacetic acid
EIAs enzyme immunoassays
EM erythema multiforme<
FDA Food and Drug Administration
FTA-ABS fluorescent treponemal antibody absorbed
g gram
G6PD Glucose-6-phosphate dehydrogenase
GFR glomerular filtration rate
GI gastrointestinal
HAV hepatitis A virus
HBV hepatitis B virus
HCV hepatitis C virus
HHV-8 human herpesvirus-8
HPA hypothalamic-pituitary-adrenal
HPV human papillomavirus
HSIL high grade cervical squamous intraepithelial lesion
HSV herpes simplex virus
HSV-1 herpes simplex virus 1
HSV-2 herpes simplex virus 2
ICP intracranial pressure
ICU intensive care unit
IFN interferon
IgG immunoglobulin G
IgM immunoglobulin M
IGRA interferon-gamma release assays
IM intramuscular
IND investigational new drug
IRIS immune reconstitution inflammatory syndrome
IRU immune recovery uveitis
IV intravenous
IVIG ntravenous immunoglobulin
JCV JC virus
KS Kaposi Sarcoma
LEEP loop electrosurgical excision procedure
LP lumbar puncture
LSIL low grade squamous intraepithelial lesion
LTBI latent tuberculosis infection
MAC Mycobacterium avium complex
MAI Mycobacterium avium intracellulare
MCD multicentric Castleman’s disease
MDR TB multi-drug-resistant tuberculosis
mg milligram
mmHg millimeters of mercury
MSM men who have sex with men
MTB Mycobacterium tuberculosis
NAA nucleic acid amplification
NNRTI non-nucleoside reverse transcriptase inhibitor
NRTI nucleoside reverse transcriptase inhibitors
NSAID non-steroidal anti-inflammatory drugs
NVP nevirapine
OI opportunistic infection
PCP Pneumocystis pneumonia
PCR polymerase chain reaction
PEL primary effusion lymphoma
PK pharmacokinetic
PML progressive multifocal leukoencephalopathy
PO orally
PORN Progressive Outer Retinal Necrosis
PPV polysaccharide vaccine
PSI pneumonia severity index
q(n)h every ”n” hours
qAM every morning
QID four times a day
qPM every evening
RPR rapid plasma reagin
RVR rapid virological response
SCr serum creatinine
SJS Stevens-Johnson syndrome
SLE systemic lupus erythematosus
SQ subcutaneous
SS single strength
STD sexually transmitted disease
SVR sustained virologic response
TB tuberculosis
TDM therapeutic drug monitoring
TE Toxoplasma encephalitis
TEN toxic epidermal necrolysis
TID three times daily
TIW three times weekly
TP-PA T. pallidum particle agglutination
TST tuberculin skin test
ULN upper limit of normal
VAIN vaginal intra-epithelial neoplasia
VDRL Venereal Disease Research Laboratory
VIII vestibulocochlear
VIN vulvar intraepithelial neoplasia
VZV varicella zoster virus
WBC white blood cell
WHO World Health Organization
XDR TB extensively drug-resistant tuberculosis
Abbreviation Drug Name
3TC lamivudine
5-FU fluorouracil
ATV/r ritonavir-boosted atazanavir
BCA bichloroacetic acid
BOC boceprevir
COBI cobicistat
ddA-TP dideoxyadenosine triphosphate
ddI didanosine
DHA dihydroartemisinin
EFV efavirenz
EMB ethambutol
EVG elvitegravir
FTC emtricitabine
INH isoniazid
MVC maraviroc
PCV13 13-valent pneumococcal conjugate vaccine
PegIFN peginterferon alfa
PI protease inhibitor
PPV23 23-valent pneumococcal polysaccharides vaccine
PZA pyrazinamide
RAL raltegravir
RBV ribavirin
RFB rifabutin
RIF rifampin
RPT rifapentine
SMX sulfamethoxazole
TCA trichloroacetic acid
TDF tenofovir disoproxil fumarate
TMP trimethoprim
TMP-SMX trimethoprim-sulfamethoxazole
TVR telaprevir
ZDV zidovudine
Documents
Section OnlyPDF (344.69 KB)
Full GuidelinePDF (3.78 MB)
Tables OnlyPDF (481.21 KB)

Download Guidelines